Alamar Biosciences, Inc
Price
FilingsNewest: Form 4, insider tradeNov 13 →Insiders5 insiders bought $8.0M in 2 open-market buys. 7 insiders sold $47.5M, 0 of 128 sales on a 10b5-1 plan.→HoldersSands Capital Alternatives 6.1%Samsara Biocapital 3.6%ARK 2.0%→Financing →
From the filings
Figures
- Cash and equivalents
- $121.5Mat the last balance sheet
- Shares outstanding
- 69.4M shareson issue
Filings, newest first
- Nov 134Insider trade
- Nov 54Insider trade
- Nov 310-QQuarterly report
- Nov 38-KResults of operations
- Sep 18-KDirector or officer change
- Aug 1313GStake over 5%, passive
- Aug 1113GStake over 5%, passive
- Aug 1010-QQuarterly report
- Aug 108-KResults of operations
- Jul 158-KOther events